Intratumoral antigen signaling traps CD8 + T cells to confine exhaustion to the tumor site
Science Immunology · 24.05.2024 · 9 (95)
DOI: 10.1126/sciimmunol.ade2094 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, erschienen am 24.05.2024. Verfasst von Munetomo Takahashi und 20 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Council Toxicology Unit, University of Cambridge, Gleeson Building, Tennis Court Road, Cambridge CB2 1QR, UK. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Signal Transduction. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, Medical Research Council, MRF_.
Abstract (Originalsprache)
Immunotherapy advances have been hindered by difficulties in tracking the behaviors of lymphocytes after antigen signaling. Here, we assessed the behavior of T cells active within tumors through the development of the antigen receptor signaling reporter (AgRSR) mouse, fate-mapping lymphocytes responding to antigens at specific times and locations. Contrary to reports describing the ready egress of T cells out of the tumor, we find that intratumoral antigen signaling traps CD8 + T cells in the tumor. These clonal populations expand and become increasingly exhausted over time. By contrast, antigen-signaled regulatory T cell (T reg ) clonal populations readily recirculate out of the tumor. Consequently, intratumoral antigen signaling acts as a gatekeeper to compartmentalize CD8 + T cell responses, even within the same clonotype, thus enabling exhausted T cells to remain confined to a specific tumor tissue site.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medical Research Council Toxicology Unit, University of Cambridge, Gleeson Building, Tennis Court Road, Cambridge CB2 1QR, UK.
- Graduate School of Medicine and Faculty of Medicine, University of Tokyo, Tokyo 113-0033, Japan.
- University of Cambridge, CRUK Cambridge Institute, Cambridge CB2 0RE, UK.
- Altos Labs Cambridge Institute, Cambridge CB21 6GP, UK.
- Department of Pharmacology and Therapeutics, University of Liverpool, Sherrington Building, Ashton Street, Liverpool L69 3G, UK.
- Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.
ORCID-Profile: Munetomo Takahashi, Vitalina Chamberlain-Evans, Juan Carlos Yam-Puc, Katarzyna Kania, Michelle Ruhle, Tiffeney Mann, Martijn J Schuijs, Paul Coupland, Dean Naisbitt, Timotheus Y F Halim, Paul A Lyons, Pietro Lio, Rahul Roychoudhuri, Klaus Okkenhaug, David J Adams, Ken G C Smith, Duncan I Jodrell, Michael A Chapman, James E D Thaventhiran
Förderung
- Wellcome Trust
- Medical Research Council
- MRF_
Zitieren
APA
Takahashi, M., So, T. Y., Chamberlain-Evans, V., Hughes, R., Yam-Puc, J. C., Kania, K., Ruhle, M., Mann, T., Schuijs, M. J., Coupland, P., Naisbitt, D., Halim, T. Y. F., Lyons, P. A., Lio, P., Roychoudhuri, R., Okkenhaug, K., Adams, D. J., Smith, K. G. C., Jodrell, D. I., …, & Thaventhiran, J. E. D. (2024). Intratumoral antigen signaling traps CD8 + T cells to confine exhaustion to the tumor site. Science Immunology, 9(95). https://doi.org/10.1126/sciimmunol.ade2094
Vancouver
Takahashi M, So TY, Chamberlain-Evans V, Hughes R, Yam-Puc JC, Kania K, et al. Intratumoral antigen signaling traps CD8 + T cells to confine exhaustion to the tumor site. Science Immunology. 2024;9(95). doi:10.1126/sciimmunol.ade2094
BibTeX
@article{Takahashi2024,
author = {Takahashi, Munetomo and So, Tsz Y and Chamberlain-Evans, Vitalina and Hughes, Robert and Yam-Puc, Juan Carlos and Kania, Katarzyna and Ruhle, Michelle and Mann, Tiffeney and Schuijs, Martijn J and Coupland, Paul and Naisbitt, Dean and Halim, Timotheus Y F and Lyons, Paul A and Lio, Pietro and Roychoudhuri, Rahul and Okkenhaug, Klaus and Adams, David J and Smith, Ken G C and Jodrell, Duncan I and Chapman, Michael A and Thaventhiran, James E D},
title = {Intratumoral antigen signaling traps CD8 + T cells to confine exhaustion to the tumor site},
journal = {Science Immunology},
year = {2024},
volume = {9},
number = {95},
doi = {10.1126/sciimmunol.ade2094}
}
EUVIMED